Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;26(10):725-740.
doi: 10.1007/s11916-022-01075-1. Epub 2022 Sep 3.

Giant Cell Arteritis: A Case-Based Narrative Review of the Literature

Affiliations
Review

Giant Cell Arteritis: A Case-Based Narrative Review of the Literature

Davis C Thomas et al. Curr Pain Headache Rep. 2022 Oct.

Abstract

Purpose of review: Giant cell arteritis (GCA) is a chronic, inflammatory condition, primarily affecting the medium and larger arteries. The purpose of this narrative review is to describe GCA in the context of headache and facial pain, based on a case and the available current literature. Understanding the etiology, pathophysiology, the associated conditions, and the differential diagnoses is important in managing GCA.

Recent findings: In a patient presenting with unilateral facial/head pain with disturbances of vision, GCA should be considered in the differential diagnosis. There is an association of GCA with several comorbid conditions, and infections including coronavirus-19 (COVID-19) infection. Management of GCA primarily depends upon the identification of the affected artery and prompt treatment. Permanent visual loss and other serious complications are associated with GCA. GCA is characterized by robust inflammation of large- and medium-sized arteries and marked elevation of systemic mediators of inflammation. An interdisciplinary approach of management involving the pertinent specialties is strongly recommended.

Keywords: Artery biopsy; Facial pain; Giant cell arteritis (GCA); Halo sign; Temporal arteritis; Vasculitis.

PubMed Disclaimer

Conflict of interest statement

Davis C Thomas, Prisly Thomas, Deep P Pillai, Dahlia Joseph, Upasana Lingaiah, Blessy C Mathai, Anjali Ravi, Surabhi Chhabra, and Priyanka Kodaganallur Pitchumani declare no conflict of interest.

Figures

Fig. 1
Fig. 1
A Longitudinal section showing perivascular hypoechoic halo. B Axial section showing the perivascular hypoechoic halo. The blue dot at the center designates the narrowed lumen
Fig. 2
Fig. 2
Histopathological features of the biopsy specimen (TI, tunica intima; TM, tunica media; TA, tunica adventitia; H&E, hematoxylin and eosin)
Fig. 3
Fig. 3
Schematic representation of the macro- and micro-anatomy of giant cell arteritis
Fig. 4
Fig. 4
Comorbidities in giant cell arteritis

References

    1. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122–1128. doi: 10.1002/art.1780330810. - DOI - PubMed
    1. Ameer MA, Peterfy RJ, Khazaeni B. Temporal arteritis. StatPearls. Treasure Island (FL): StatPearls Publishing. Copyright © 2022, StatPearls Publishing LLC.; 2022.
    1. Borchers AT, Gershwin ME. Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev. 2012;11(6–7):A544–A554. doi: 10.1016/j.autrev.2012.01.003. - DOI - PubMed
    1. Schwedt TJ, Dodick DW, Caselli RJ. Giant cell arteritis. Curr Pain Headache Rep. 2006;10(6):415–420. doi: 10.1007/s11916-006-0071-6. - DOI - PubMed
    1. Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, et al. 2018 update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020;79(1):19–30. doi: 10.1136/annrheumdis-2019-215672. - DOI - PubMed

Substances